Sweet relief.

AuthorVerdezoto, Maria Elena
PositionOral Lyn, insuline-delivery system developed by Generex Biotechnology and Pharmabrand - Art

Six percent of the people in the world are diabetics and need insulin, which for 80 years has meant frequent injections using an old-fashioned syringe. Now a strategic alliance between Generex Biotechnology, a Canadian company, and Ecuador's Pharmabrand is making the process less painful. They created Oral Lyn, device for the mouth made in the Andean country. Oral Lyn enters the body as an aerosol under the tongue, sending the medicine to the blood by way of mucous in the mouth. It can be carried in your pocket and does not need refrigeration. It is being sold in Ecuador for US$32 a box, each of which holds two of the aerosol devices and lasts on average 15 days for patients who need two to three doses a day. "Diabetes is turning into a pandemic, and because of that we worry about how to improve the quality of life of these people," says Robert Cid, president of Pharmabrand. The companies spent nearly $20 million to...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT